Home > Business Development > In-licensing  
 
Hyundai is your best choice as a trusted partner to help your business get a rapid and efficient entry into the Korean market and achieve a stable settlement.

Hyundai has outstanding professional teams that are considered the most experienced in clinical trials, regulatory affairs, and marketing in Korea.

The goal of Hyundai is to make significant scientific contributions, and to be a recognized performance leader in the domestic market where we provide innovative and valuable drugs to patients.

Hyundai accomplished fast market penetration of licensed products by conducting multinational trials simultaneously with licensors.

Hyundai offers its partners various business options such as co-marketing, copromotion, joint-ventures and equity investment, and is open to exploring value-adding partnerships in a broad range of cooperation.

Following therapeutic areas are targets that Hyundai is actively seeking and focusing on:
  • Cardiovascular disorder such as hypertension
  • Endocrinology disorder such as Type I, II Diabetes & Diabetic complications
  • CNS disorder such as Depression, Schizophrenia, Anxiety disorder, Insomnia, Alzheimer's disease, Parkinson's disease and Various pain types
  • Ophthalmic disorder
  • Respiratory disorder
  • Oncology disorder
  • Degenerative/Age-related diseases
If you have a potential partnering opportunity to discuss with Hyundai, please email (BD@hdpharm.co.kr)

YEAR
EVENT
2022
ASKA Pharmaceutical
Exclusive License and Supply Agreement for Slinda, an estrogen-free progestin only oral contraceptive
2020
Linepharma International
Exclusive Marketing and Distribution Agreement for Mifegymiso, a combination product for the medical termination of a pregnancy

Ferring Pharmaceuticals Korea
Co-Promotion Agreement for three women’s health products (Tractocile Injection, Duratocin RTS Injection, Propess Vaginal SR Tablet)

Sandoz Korea
Co-Promotion Agreement for three anti-depressant products (Escitalopram Tablet, Sertraline Tablet, Paroxetine Tablet)
2019
NEUROCHLORE (France)
Exclusive License Agreement for the Autism Spectrum Disorder treatment candidate

Seoul Saint Mary’s Hospital & KRICT (Korea)
Exclusive License Agreement for the “Composition for Hardening Soft Tissue”

BAUSCH & LOMB (USA)
Exclusive Distribution Agreement for Emerade, an adrenaline auto-injector for anaphylaxis
2018
MITHRA Pharmaceuticals (Belgium)
Exclusive License and Supply Agreement for Estelle, a novel combined oral contraceptive (COC) product candidate
2016
ACERUS Pharmaceuticals (Canada)
Exclusive License and Supply Agreement for Natesto, a testosterone nasal gel for replacement therapy in adult males
2015
ASLAN Pharmaceuticals (Singapore)
Collaboration and License Agreement for ASLAN001 (Varlitinib), a drug candidate for the treatment of advanced biliary tract cancer

Takeda Korea
Exclusive Distribution Agreement for Tachosil (Pre-rolled), a dual action surgical hemostatic patch

CHEMO (Spain)
Exclusive License and Supply Agreement for Lania (Levonorgestrel, Ethinyl Estradiol), a generic combined oral contraceptive (COC) product

Pfizer Korea
Co-Promotion Agreement for Duavive, a product for menopausal hormone therapy (MHT)

Abbott Korea
Co-Promotion Agreement for Hokunalin Patch, a treatment of relief of various symptoms, such as dyspnea, resulting from airway obstruction in bronchial asthma, acute bronchitis, chronic bronchitis, and pulmonary emphysema
2014
DUCHESNAY (Canada)
Exclusive License and Supply Agreement for Dicletin, a product for treating nausea and vomiting in pregnancy

CHEMO (Spain)
Exclusive License and Supply Agreement for Bonita (Desogestrel, Ethinyl Estradiol), a generic combined oral contraceptive (COC) product
2012
Takeda Korea
Exclusive Distribution Agreement for Tachosil, a dual action surgical hemostatic patch
2011
Bausch & Lomb South Asia Inc.
Co-Promotion Agreement for Ocuvite, an eye vitamin and mineral supplements with Lutein

Ophtecs (Japan)
Exclusive License and Supply Agreement for Ruping, a preservativefree artificial tear
 
main_footer